Skip to content

Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity.

S Che, M Johnson, Glen R. Hanson, James W. Gibb

European Journal of Pharmacology December 1, 1995 DOI: 10.1016/0926-6917(95)90065-9 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental animal study Peer reviewed
Population Rats (Sprague-Dawley implied by context; not stated in abstract)
Interventions 3 4-methylenedioxymethamphetamine N-tert-butyl-alpha-phenylnitrone
Dose 3,4-methylenedioxymethamphetamine 20 mg/kg, s.c.; N-tert-butyl-alpha-phenylnitrone 200 mg/kg, i.p.
Duration 2 h after drug treatment
Topics MDMA
Keywords Brain stem Hippocampus Corpus striatum Cerebral cortex Animals Rats, sprague-dawley Nitrogen oxides N-methyl-3,4-methylenedioxyamphetamine Cyclic n-oxides Tryptophan hydroxylase Serotonin agents Free radical scavengers Body temperature Drug interactions Male
Key findings MDMA (20 mg/kg) decreased tryptophan hydroxylase activity in rat hippocampus, striatum, and frontal cortex to 61%, 65%, and 71% of control levels, respectively, when rats were hyperthermic, but had no effect when rats were hypothermic. The authors conclude that body temperature plays a prominent role in the acute MDMA-induced decrease in tryptophan hydroxylase activity, possibly via free radical formation.

Abstract

Brain tryptophan hydroxylase activity decreases within 15 min after a single administration of 3,4-methylenedioxymethamphetamine. In the present study, the effect of body temperature on this acute decrease of tryptophan hydroxylase activity was examined. 2 h after a single dose of 3,4-methylenedioxymethamphetamine (20 mg/kg, s.c.), rats exhibited hyperthermia (38.7 degrees C) or hypothermia (35.8 degrees C) when maintained at 25 degrees C or 6 degrees C, respectively. The rectal temperature of control animals maintained at 6 degrees C was not altered. Tryptophan hydroxylase activity measured in the hippocampus, striatum and frontal cortex of hyperthermic rats treated with 3,4-methylenedioxymethamphetamine was decreased to 61%, 65%, and 71% of control levels, respectively, 2 h after drug treatment. However, in hypothermic rats, 3,4-methylenedioxymethamphetamine had no effect on tryptophan hydroxylase activity in the hippocampus, striatum or frontal cortex. Non-drug-induced hyperthermia or hypothermia did not affect tryptophan hydroxylase activity. Since hypothermia may prevent the 3,4-methylenedioxymethamphetamine-induced decrease in tryptophan hydroxylase activity by reducing the formation of free radicals, the effect of a free radical scavenging agent, N-tert-butyl-alpha-phenylnitrone, was examined. N-tert-butyl-alpha-phenylnitrone (200 mg/kg, i.p.) alone caused hypothermia but had no direct effect on tryptophan hydroxylase activity. Preadministration of N-tert-butyl-alpha-phenylnitrone prevented 3,4-methylenedioxymethamphetamine from raising the temperature above normal and attenuated the drug-induced decrease in tryptophan hydroxylase activity in hippocampus, striatum and frontal cortex. However, when the rats treated with a combination of N-tert-butyl-alpha-phenylnitrone and 3,4-methylenedioxymethamphetamine were maintained at hyperthermic conditions, N-tert-butyl-alpha-phenylnitrone had no protective effect. These results suggest that body temperature plays a prominent role in the 3,4-methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity.

Comparable studies

Other preclinical and animal studies on MDMA, most cited first.

Citations in the library

Cited by 8

and 3 more in the library

Cites 9

and 4 more in the library

Explore topics